Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a dedicated Locations section listing study sites by state (Arizona, Connecticut, Florida, Massachusetts, Texas, Virginia) and updated to revision v3.3.3. Removed the separate state-specific 'Locations' subsections (Arizona Locations, Connecticut Locations, etc.) from the prior revision.SummaryDifference0.7%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page; no study content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved the government funding/operating status notice banner from the page, which previously warned users about potential delays and where to check operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedThe screenshots show essentially the same study details page with no substantial edits to core content such as eligibility criteria, interventions, or outcomes; only minor UI/formatting differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedAdded a government-funding notice and updated the version to v3.2.0, while removing the old v3.1.0 version tag.SummaryDifference5%

- Check100 days agoChange DetectedUpdated to Revision: v3.1.0 with expanded contact emails/phone numbers; removed obsolete revision v3.0.2. No changes detected to pricing, stock, or time slots.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.